Skip to main content
Atrás
Watch Compare

Arcadia Biosciences, Inc.

Calidad de datos: 100%
RKDA
Nasdaq Energy Oil & Gas Extraction
$1.34
▲ $0.01 (0.75%)
Cap. Mercado: 2.76 M
Precio
$1.34
Cap. Mercado
2.76 M
Rango del Día
$1.33 — $1.38
Rango de 52 Semanas
$1.30 — $6.71
Volumen
7,500
Apertura $1.37
Promedio 50D / 200D
$1.81
25.91% below
Promedio 50D / 200D
$3.28
59.15% below

Quick Summary

Puntos Clave

Revenue declined -8.00% annually over 5 years
Negative free cash flow of -4.74 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.29%
Capital efficient — spends only 0.00% of revenue on capex

Crecimiento

Revenue Growth (5Y)
-8.00%
Below sector avg (9.65%)
Revenue (1Y)-3.71%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-46.89%
Below sector avg (5.31%)
ROIC-32.25%
Net Margin-48.15%
Op. Margin-51.46%

Seguridad

Debt / Equity
N/A
Current Ratio3.67
Interest Coverage-11.31

Valoración

PE (TTM)
-1.18
Below sector avg (12.22)
P/B Ratio0.51
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Energy (407 pares)
Métrica Acción Mediana del Sector
P/E -1.2 12.2
P/B 0.5 2.1
ROE % -46.9 5.3
Net Margin % -48.2 8.5
Rev Growth 5Y % -8.0 9.6
D/E — 0.5

All Fundamental Metrics
Growth
Revenue Growth (1Y) -3.71% Revenue Growth (3Y) -4.53%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8.00% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.86 M Net Income (TTM) -2.34 M
ROE -46.89% ROA -28.57%
Gross Margin N/A Operating Margin -51.46%
Net Margin -48.15% Free Cash Flow (TTM) -4.74 M
ROIC -32.25% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.67
Interest Coverage -11.31 Asset Turnover 0.59
Working Capital 6.10 M Tangible Book Value 5.40 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.18 Forward P/E N/A
P/B Ratio 0.51 P/S Ratio 0.57
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -171.94%
Market Cap 2.76 M Enterprise Value 1.64 M
Per Share
EPS (Diluted TTM) -1.71 Revenue / Share 2.36
FCF / Share -2.30 OCF / Share -2.30
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.00% FCF Conversion 202.61%
SBC-Adj. FCF -5.11 M Growth Momentum 4.29

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.86 M 5.05 M 5.33 M 9.96 M 6.78 M
Net Income -2.34 M -7.04 M -13.98 M -15.38 M -14.66 M
EPS (Diluted) -1.71 -5.17 — -25.65 —
Gross Profit — — — — —
Operating Income -2.50 M -3.65 M -13.94 M -18.82 M -35.53 M
EBITDA — — — — —
R&D Expenses 9,000.0 53,000.0 1.39 M 1.51 M 3.89 M
SG&A Expenses 7.00 M 9.64 M 14.51 M 18.05 M 22.94 M
D&A — — — — —
Interest Expense 221,000.0 782,000.0 695,000.0 289,000.0 20,000.0
Income Tax 8,000.0 8,000.0 8,000.0 14,000.0 2,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6.55 M 13.52 M 19.71 M 28.92 M 43.92 M
Total Liabilities 2.41 M 7.29 M 7.00 M 8.02 M 12.72 M
Shareholders' Equity 4.14 M 6.22 M 12.84 M 21.03 M 31.09 M
Total Debt — — — — 0.0
Cash & Equivalents 259,000.0 4.24 M 6.52 M 20.64 M 28.69 M
Current Assets 6.36 M 9.24 M 14.97 M 25.40 M 35.39 M
Current Liabilities 2.06 M 2.56 M 3.59 M 4.21 M 5.04 M